Kezar Life SciencesKZR
那斯達克 · USD
6.85
-0.33
(-4.60%)
收盤 03/14 03:41 (UTC+8)
03/14 03:41 (UTC+8)
Kezar Life SciencesKZR
6.85
-0.33
(-4.60%)
財務數據
損益表
- -
- 0.07
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | 7,000 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | 7,000 | - |
營業費用 | 11,715 | 14,599 | 17,629 | 21,563 | 21,948 | 23,383 | 23,711 | 34,589 | 32,527 | 26,784 |
研發費用 | 6,914 | 9,583 | 12,180 | 16,030 | 16,242 | 16,298 | 17,172 | 22,642 | 23,738 | 20,999 |
推銷及管理費用 | 4,801 | 5,016 | 5,449 | 5,545 | 5,706 | 5,603 | 6,539 | 5,760 | 8,789 | 5,785 |
非經常性項目費用 | - | - | - | -12 | - | 1,482 | - | 6,187 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -11,715 | -14,599 | -17,629 | -21,563 | -21,948 | -23,383 | -23,711 | -34,589 | -25,527 | -26,784 |
其他收入及費用 | -161 | 1,197 | 1,420 | 2,938 | 2,038 | 2,237 | 2,453 | 2,728 | 2,820 | 2,861 |
利息費用 | -649 | 302 | 347 | 1,593 | 403 | 401 | 400 | 399 | 396 | 385 |
稅前純益 | -11,227 | -13,704 | -16,556 | -20,218 | -20,313 | -21,547 | -21,658 | -32,260 | -23,103 | -24,308 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -11,227 | -13,704 | -16,556 | -20,218 | -20,313 | -21,547 | -21,658 | -32,260 | -23,103 | -24,308 |
基本每股稅後盈餘(元) | -1.53 | -1.87 | -2.00 | -3.00 | -0.28 | -0.30 | -0.30 | - | -0.32 | -0.34 |
稀釋每股稅後盈餘(元) | -1.53 | -1.87 | -2.27 | -2.77 | -0.28 | -0.29 | -0.30 | -0.44 | -0.32 | -0.33 |
基本平均股數(千股) | 7323.00 | 7311.00 | 7305.00 | 7300.00 | 72962.00 | 72845.00 | 72799.00 | - | 72681.00 | 72461.00 |
稀釋平均股數(千股) | 7323.00 | 7311.00 | 7305.00 | 7300.00 | 72962.00 | 72845.00 | 72799.00 | - | 72681.00 | 72461.00 |
還原基本每股稅後盈餘(元) | -1.53 | -1.87 | -2.00 | -3.00 | -2.78 | -2.96 | -2.98 | - | -3.18 | -3.40 |
還原稀釋每股稅後盈餘(元) | -1.53 | -1.87 | -2.27 | -2.77 | -2.79 | -2.92 | -2.98 | -4.44 | -3.20 | -3.30 |
還原基本平均股數(千股) | 7,323 | 7,311 | 7,305 | 7,300 | 7,296 | 7,284 | 7,279 | - | 7,268 | 7,246 |
還原稀釋平均股數(千股) | 7,323 | 7,311 | 7,305 | 7,300 | 7,296 | 7,284 | 7,279 | - | 7,268 | 7,246 |
EBITDA(千元) | -12,106 | -13,704 | -16,487 | -19,215 | -20,812 | -22,209 | -22,447 | -33,054 | -24,137 | -25,434 |